Tax

Federal Tax (Current)

Vertex Pharmaceuticals Federal Tax (Current) remained flat by 0.0% to $169.78M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.7%, from $176.23M to $169.78M. Over 2 years (FY 2023 to FY 2025), Federal Tax (Current) shows a downward trend with a -13.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement
SectionTax
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

Changes reflect fluctuations in taxable income or shifts in federal tax legislation affecting the company.

Detailed definition

The portion of the total income tax provision that is currently payable to the federal government based on the taxable i...

Peer comparison

Standard line item in corporate tax reconciliations for all U.S.-based public companies.

Metric ID: is_msft_current_federal_tax_expense

Historical Data

3 years
 FY'23FY'24FY'25
Value$900.40M$704.90M$679.10M
YoY Change—-21.7%-3.7%
Range$679.10M – $900.40M
CAGR-13.2%
Avg YoY Growth-12.7%
Median YoY Growth-12.7%
Current Streak2+ years decline

Frequently Asked Questions

What is Vertex Pharmaceuticals's federal tax (current)?
Vertex Pharmaceuticals (VRTX) reported federal tax (current) of $169.78M in Q4 2025.
How has Vertex Pharmaceuticals's federal tax (current) changed year-over-year?
Vertex Pharmaceuticals's federal tax (current) decreased by 3.7% year-over-year, from $176.23M to $169.78M.
What is the long-term trend for Vertex Pharmaceuticals's federal tax (current)?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's federal tax (current) has grown at a -13.2% compound annual growth rate (CAGR), from $900.40M to $679.10M.
What does federal tax (current) mean?
The amount of income tax currently owed to the federal government for the period.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.